Filing Details

Accession Number:
0001991925-23-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-18 16:32:12
Reporting Period:
2023-09-14
Accepted Time:
2023-09-18 16:32:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Neubase Therapeutics Inc. NBSE Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1991925 Symetryx Corp 2828 Bathurst St #400
Toronto A6 M6B3A7
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2023-09-14 129,108 $1.44 153,337 No 4 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2023-09-15 103,337 $1.26 50,000 No 5 S Direct
Common Stock, Par Value $0.0001 Per Share Disposition 2023-09-18 50,000 $1.19 0 No 5 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 5 S Direct
No 5 S Direct